AVNS Avanos Medical Inc
- Stocks
- Healthcare
- NYSE: AVNS
Price (delayed)
$11.68
Market cap
$540.13M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.36
Enterprise value
$584.03M
Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address
Highlights
The quick ratio has increased by 46% year-on-year
Avanos Medical's debt has decreased by 34% YoY and by 17% from the previous quarter
The company's equity fell by 32% YoY
The gross margin has declined by 3% year-on-year
Key stats
What are the main financial stats of AVNS
Market
Valuations
Earnings
Shares outstanding
46.24M
Market cap
$540.13M
Enterprise value
$584.03M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.64
Price to sales (P/S)
0.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.85
Revenue
$689.2M
Gross profit
$376.3M
Operating income
-$395.6M
Net income
-$384.6M
EBIT
-$388.3M
EBITDA
-$344.6M
Free cash flow
$114M
Per share
Balance sheet
Liquidity
EPS
-$8.36
EPS diluted
-$8.37
Free cash flow per share
$2.48
Book value per share
$18.25
Revenue per share
$14.98
TBVPS
$11.84
Total assets
$1.11B
Total liabilities
$268.4M
Debt
$140.9M
Equity
$839.4M
Working capital
$215.2M
Debt to equity
0.17
Current ratio
2.57
Quick ratio
1.47
Net debt/EBITDA
-0.13
Margins
Efficiency
Dividend
EBITDA margin
-50%
Gross margin
54.6%
Net margin
-55.8%
Operating margin
-57.4%
Return on assets
-27.6%
Return on equity
-37.3%
Return on invested capital
-76.5%
Return on capital employed
-40%
Return on sales
-56.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AVNS stock price
How has the Avanos Medical stock price performed over time
Intraday
-1.43%
1 week
-3.55%
1 month
-4.58%
1 year
-49.13%
YTD
-26.63%
QTD
-4.58%
Financial performance
How have Avanos Medical's revenue and profit performed over time
Revenue
$689.2M
Gross profit
$376.3M
Operating income
-$395.6M
Net income
-$384.6M
Gross margin
54.6%
Net margin
-55.8%
The gross margin has declined by 3% year-on-year
Avanos Medical's net margin has increased by 2.1% from the previous quarter
Price vs fundamentals
How does AVNS's price correlate with its fundamentals
Growth
What is Avanos Medical's growth rate over time
Valuation
What is Avanos Medical stock price valuation
P/E
N/A
P/B
0.64
P/S
0.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.85
AVNS's price to book (P/B) is 41% less than its 5-year quarterly average of 1.1 and 19% less than its last 4 quarters average of 0.8
The company's equity fell by 32% YoY
The P/S is 58% lower than the 5-year quarterly average of 1.9 and 34% lower than the last 4 quarters average of 1.2
Efficiency
How efficient is Avanos Medical business performance
The return on assets has declined by 8% since the previous quarter
The ROE has contracted by 7% from the previous quarter
AVNS's ROIC is down by 3.4% from the previous quarter
The ROS has grown by 2.4% from the previous quarter
Dividends
What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AVNS.
Financial health
How did Avanos Medical financials performed over time
The quick ratio has increased by 46% year-on-year
Avanos Medical's total liabilities has decreased by 38% YoY and by 18% from the previous quarter
Avanos Medical's debt is 83% less than its equity
Avanos Medical's debt has decreased by 34% YoY and by 17% from the previous quarter
The company's equity fell by 32% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.